<DOC>
	<DOCNO>NCT01347307</DOCNO>
	<brief_summary>This study evaluate local control rate well acute late toxicity rate stereotactic body radiotherapy ( SBRT ) treatment spine metastases benign spine tumor .</brief_summary>
	<brief_title>Stereotactic Body Radiotherapy Spine Tumors</brief_title>
	<detailed_description>This study single site , non-randomized , prospective , phase IV trial . Patients compose 2 group : Spine Metastases OR Benign Spine Tumors . Data collect include patient demographic , pathology data , tumor stage , SBRT dose fractionation scheme , dose receive adjacent critical normal tissue , tumor recurrence data , acute late toxicity . Follow data collect patient 's standard office visit . The anticipated duration study 5 year</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Meningioma</mesh_term>
	<mesh_term>Arteriovenous Malformations</mesh_term>
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Neurilemmoma</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Nerve Sheath Neoplasms</mesh_term>
	<mesh_term>Chordoma</mesh_term>
	<mesh_term>Paraganglioma</mesh_term>
	<mesh_term>Carotid Body Tumor</mesh_term>
	<mesh_term>Spinal Cord Neoplasms</mesh_term>
	<mesh_term>Spinal Neoplasms</mesh_term>
	<criteria>Eligibility Criteria : Patient age &gt; = 18 year performance status 03 Vertebral and/or paraspinal metastasis , without prior surgery and/or fractionate radiotherapy Benign extradural spine tumor chordomas , meningioma , schwannomas , neurofibromas , paragangliomas , arteriovenous malformation ( AVMs ) . Established histologic diagnosis benign malignant tumor spine . Arteriovenous malformation spine identify radiographically ( biopsy ) Welldefined lesion involve 2 adjacent vertebral level spinal segment Minimal spinal canal compromise rapidly progressive . Ideally , tumor within 5 mm spinal cord . If chemotherapy plan , ideally give within 30 day start radiation resume least 2 week complete radiation . In addition , recommend perform SBRT target antiangiogenesis therapy plan within 2 month procedure . Signed studyspecific consent form Lesion involve &gt; 3 adjacent vertebral level Overt spinal instability Neurologic deficit due bony fragments/bony compression neural structure Prior radiotherapy involve level ( ) within 3 month radiosurgery , one prior course radiotherapy involve level ( ) , 45 Gy previous radiation exposure involve level ( ) Rapidly progressive spinal cord compromise neurological deficit Paralysis , otherwise compromise motor function due radiographically confirm cord compression Patient unable undergo MRI Pregnant lactate woman , due potential exposure fetus RT unknown effect RT lactate female Patients psychiatric addictive disorder would preclude obtain informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>stereotactic radiotherapy</keyword>
	<keyword>spinal metastasis</keyword>
	<keyword>vertebral metastasis</keyword>
	<keyword>benign spinal tumor</keyword>
</DOC>